|
|
|
| home > white papers > CRSF Label - Child-Resistant Blister Packs With Booklet Label - Faubel & Co. Nachfolger GmbH |
|
|
 WHITE PAPERS |
|
Faubel & Co. Nachfolger GmbH
|
|
CRSF Label - Child-Resistant Blister Packs With Booklet Label
|
|
This case study explains how Faubel was commissioned by a leading global pharmaceutical company to develop a label for an aluminum blister pack with 14 cavities, which was used as part of a multinational clinical trial. This label was intended to both protect infants from erroneous ingestion and facilitate use by seniors.
The project was primarily focused on the functionality of the packaging solution, including with regard to the integrity of the inner soft capsules. Due to different countries participating in the clinical trial, the objective was to achieve certification according to EU standard DIN 14375 and US standard 16 CFR § 1700.20 with the final concept as well as to accommodate more than 20 different languages. Despite the high requirements in terms of function and the standard, Faubel was anxious to provide an efficient packaging concept.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman
Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who was serving as Chairman on an interim basis on behalf of the Board.
More info >> |
|
 |
White Papers |
 |
|
Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections
IBT Bioservices
Introduction
Staphylococcus aureus (SA) is a ubiquitous, formidable
Gram-positive pathogen associated with skin and soft tissue, as well as
lifethreatening systemic infections. SA is a leading cause of hospital- and
community-associated infections worldwide, affecting humans and animals. The
wide range of pathologies reflects the diverse abilities of this microbe to
escape the innate and adaptive immune response using virulence factors. Since
its first emergence in the 1960s methicillin-resistant SA (MRSA) has become
endemic in hospitals and healthcare settings worldwide. In the 1990s, community
associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a
major global challenge.
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
.jpg)
